The following is issued on behalf of the Hospital Authority:

     ​The Hospital Authority (HA) announced today (April 3) that the 15th China Chest Pain Centers Congress (CCPCC 2026) is being held at the Hong Kong Convention and Exhibition Centre over two days (April 3 and 4), bringing together about 3 000 medical professionals from Hong Kong, Chinese Mainland, the Belt and Road countries and regions and around the world. This marks the first time the Congress is being held in Hong Kong, with the city serving as an important bridge in bringing national chest pain treatment standards onto the international stage, representing a significant milestone for the Congress.

     This year's Congress features 16 professional forums and over 200 specialised lectures, covering cutting-edge healthcare innovations, AI-assisted clinical decision-making, intelligent emergency response systems, and international accreditation standards. The event aims to establish a platform for academic exchange, innovation, and collaboration in chest pain centre development and cardiovascular medicine, facilitating the sharing of new medical knowledge and experience, and collectively exploring the latest directions in contemporary cardiovascular healthcare services.

     The Congress is jointly organised by the HA, the National Clinical Research Center for Interventional Medicine, the Guangdong Chest Pain Centers Association, and the Chinese Cardiovascular Association. The opening ceremony was held this morning, officiated by the Secretary for Health, Professor Lo Chung-mau; Second-Level Inspector of the Health Commission of Guangdong Province, Mr Wu Jingzen; Chairperson of the Organising Committee (Chinese Mainland), Academician Professor Ge Junbo; Chairperson of the Organising Committee (Chinese Mainland), Professor Yong Huo; Legislative Council Member for the Medical and Health Services functional constituency, Dr Hon David Lam; the Dean of the Faculty of Medicine, the Chinese University of Hong Kong, Professor Philip Chiu, the HA Chairman, Mr Henry Fan; and the HA Chief Executive and the Chairperson of the Organising Committee (Hong Kong), Dr Libby Lee.

     Mr Fan stated that CCPCC 2026 being held in Hong Kong for the first time fully demonstrates Hong Kong's unique position as an international hub for medical exchange.

     Mr Fan said "Countries and regions around the world are currently facing the severe challenge of a growing number of acute cardiac cases. Strengthening medical exchange and collaboration, and driving medical innovation, are therefore of paramount importance. I believe this Congress will bring fruitful academic achievements to all attendees and inject new momentum into the global development of cardiovascular medicine, ultimately benefiting more patients."

     Dr Lee, in her opening address, stated that the HA has always been committed to enhancing the quality of acute cardiac services in public hospitals and actively collaborates closely with Chinese Mainland counterparts to promote the integration of high-quality medical services.

     Dr Lee said "Hong Kong's healthcare system is renowned for its efficiency, professionalism, and excellence. The Chest Pain Centre at Queen Mary Hospital has achieved accreditation under the National Chest Pain Centre Construction Standards, and the Chest Pain Centre at Prince of Wales Hospital will also undergo accreditation in due course. Establishing chest pain centres have yielded significant results in improving chest pain treatment processes and enhancing service efficiency, benefiting patients and fully demonstrating Hong Kong's deep commitment to standardised care, multidisciplinary coordination, and timely intervention. Hong Kong's experience can also serve as an important reference for global chest pain centre development. I look forward to collaborating with the Chinese Mainland and international medical communities through this Congress to jointly promote innovation and sustainable development in cardiovascular medicine."

     During the CCPCC 2026, the "Chest Pain Center Construction and Accreditation Standards (International Version)" has been officially issued. This standard provides a framework for healthcare institutions worldwide to establish high-quality chest pain centres, which aims to standardise treatment protocols, improve clinical outcomes, enhance clinical prognosis, promote the standardised development of chest pain centres internationally, and ultimately raise the overall level of global chest pain treatment.

Ends/Friday, April 3, 2026
Issued at HKT 13:30

NNNN